{"transactions":[{"id":696860,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-04T21:03:20.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":false,"shares":36375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":109125,"derivative":{"underlying":"Common Stock","underlying_shares":36375},"source":{"system":"sec-edgar","filing":"0002076327-26-000006","document":"form4-08042026_090816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000207632726000006/form4-08042026_090816.xml","form_type":"4"}},{"id":696859,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-04T21:03:20.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12385,"price":5.2,"value":64402.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4."}],"balance_after":23990,"source":{"system":"sec-edgar","filing":"0002076327-26-000006","document":"form4-08042026_090816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000207632726000006/form4-08042026_090816.xml","form_type":"4"}},{"id":696858,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-04T21:03:20.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":true,"shares":36375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":36375,"source":{"system":"sec-edgar","filing":"0002076327-26-000006","document":"form4-08042026_090816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000207632726000006/form4-08042026_090816.xml","form_type":"4"}},{"id":915784,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-06T23:06:23.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":334900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":334900,"derivative":{"exercise_price":3.61,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":334900},"source":{"system":"sec-edgar","filing":"0002076327-26-000002","document":"form4-02062026_110219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000207632726000002/form4-02062026_110219.xml","form_type":"4"}},{"id":915783,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-06T23:06:23.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":95700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":95700,"derivative":{"underlying":"Common Stock","underlying_shares":95700},"source":{"system":"sec-edgar","filing":"0002076327-26-000002","document":"form4-02062026_110219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000207632726000002/form4-02062026_110219.xml","form_type":"4"}},{"id":1074104,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-05T20:33:44.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":510000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-07-31","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001415889-25-021045","document":"form4-08052025_080841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000141588925021045/form4-08052025_080841.xml","form_type":"4"}},{"id":1074103,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":26569,"kind":"person","name":"Kolbeck Roland Wilhelm","position":1,"cik":"0002076327","reported_name":"Kolbeck Roland Wilhelm","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-05T20:33:44.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":145500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":145500,"derivative":{"underlying":"Common Stock","underlying_shares":145500},"source":{"system":"sec-edgar","filing":"0001415889-25-021045","document":"form4-08052025_080841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000141588925021045/form4-08052025_080841.xml","form_type":"4"}}]}